PACIRA BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 29.65 USD | +11.84% |
|
+10.02% | -12.12% |
| May. 08 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
| May. 07 | Transcript : Pacira BioSciences, Inc., Q1 2024 Earnings Call, May 07, 2024 |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PACIRA BIOSCIENCES, INC. | Other Pharmaceuticals | +11.84% | +10.02% | -12.12% | -29.84% | -35.88% | 1.23B |  |  | |
- Stock Market
- Equities
- PCRX Stock
- Charts Pacira BioSciences, Inc.
- Relative Strength Chart